MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JACKSON, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JACKSON, R. C.

Molecular Pharmacology, Vol 18, 281-286, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

Modulation of Methotrexate Toxicity by Thymidine: Sequence-Dependent Biochemical Effects

ROBERT C. JACKSON 1

1 Laboratory for Experimental Oncology, Indiana University School of Medicine, Indianapolis, Indiana 46223

Biochemical consequences of treatment with combinations of methotrexate (MTX) and thymidine (dThd) were examined in four mammalian cell lines in vitro. When 40 µM dThd was added to medium, 1 h after a lethal dose of MTX, fibroblasts and lymphoblasts were partially protected, but N1S1 tumor cells were not. Cytotoxicity of this combination correlated with cellular thymidylate synthetase activity, and in the presence of MTX, followed by dThd, N1S1 tumor cells accumulated dihydrofolate, whereas dihydrofolate accumulation was less extensive in the other cell lines. In fibroblasts, lymphoblasts, and N1S1 tumor cells, MTX caused a marked accumulation of cellular deoxyuridylate. This effect was decreased, but not eliminated, by administration of dThd 1 h after MTX. The effects of administration of dThd (40 µM) 2 h before MTX were markedly different from the effects of dThd after MTX; no accumulation of deoxyunidylate or dihydrofolate was observed, and the dThd pretreatment conferred a greater degree of protection from MTX toxicity than dThd "rescue" in fibroblasts, lymphoblasts, and N1S1 tumor cells. In N1S1 cells MTX had a pronounced antipunine effect, as measured by the decrease in dGTP pools; this effect was largely prevented by dThd pretreatment, but dThd administration after MTX restored the dTTP pool without abolishing the antipunine effect of the MTX. The abolition of the MTX antipurine effect by dThd pretreatment is attributed to decreased cellular thymidylate synthetase activity consequent upon the reduction in deoxyunidylate caused by dThd pretreatment. In cells of the well-differentiated Morris hepatoma 8999S, pretreatment with 40 µM dThd gave no protection from MTX, though partial protection was obtained at 100 µM dThd.

Note:
ACKNOWLEDGMENT The author thanks Mr. L. Soliven for skilled technical assistance.

Submitted on December 17, 1979
Accepted on March 24, 1980







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics